Baxter (BAX) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Baxter (BAX) over the last 10 years. The current PE ratio for Baxter as of February 16, 2018 is 26.64.
|Medical||Medical Products Manufacturing||$36.139B||$10.561B|
|Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.|